SG
NKGN

StoneX Group’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

StoneX Group’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,000
Closed -$97K – 763
2022
Q1 		$97K Buy
+10,000
New +$96.9K 0.01% 530

Other funds holding NKGN

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

StoneX Group's NKGN Position: Q2 2022 in Review

StoneX Group sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q2 2022, closing a stake of 10,000 shares — an estimated $97K sold.

StoneX Group first reported a position in NKGN in Q1 2022 and held it in 1 quarter. The position peaked at $97K in Q1 2022. 48 funds tracked by Wall St. Rank hold NKGN as of Q2 2022.

  • StoneX Group reported no remaining NKGen Biotech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • StoneX Group sold 10,000 NKGen Biotech, Inc. Common Stock shares in Q2 2022, an estimated $97K.
  • StoneX Group first reported a position in NKGen Biotech, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • StoneX Group's NKGen Biotech, Inc. Common Stock position peaked at $97K in Q1 2022.
  • 48 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q2 2022.

Based on StoneX Group's 13F filing for Q2 2022, filed 27 Jul 2022.